Navigation Links
Women Well-Informed About Breast Cancer, Yet Lacking Knowledge,About Current Treatments, New Survey Finds

-- CancerCare offers five questions to help women learn about breast cancer therapy advances --

NEW YORK, June 12, 2007 – According to a new GfK Roper Public Affairs survey sponsored by CancerCare, a national nonprofit cancer support organization, while the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment. Fewer than one out of four (23 percent) women ages 50-65 have heard of new therapies for breast cancer, revealing a gap between awareness and information that women can use toward better treatment.

"These survey results suggest that many women still lack essential disease treatment information, which reinforces the need for women to educate themselves to help get the best treatment," said Diane Blum, MSW, executive director of CancerCare. "While great progress has been made in breast cancer awareness through public education and increased media coverage, women with breast cancer would benefit from more information about advances in treatments after surgery."

According to the survey, nearly all respondents were aware of chemotherapy and radiation. However, fewer than one out of four had heard of newer therapies such as aromatase inhibitors or monoclonal antibodies, nor were they informed about their benefits.

Doctor-patient dialogue is vital

If diagnosed, the majority of respondents said they would actively work with their doctor to identify the proper treatment. The survey also found that 71 percent of women would research the condition on their own in addition to discussing treatment options with their doctor. However, 86 percent were not certain they would know what questions to ask.

"Communication between the patients and their physicians is so important because it empowers them to take an active role in their treatment decisions," explained Dr. Gary Frenette, MD PhD Medical Oncologist with Carolinas Medical Center. "With essential information, patients can work with their physicians to achieve the best possible outcomes in the management of their diagnosis."

Key questions

Today, many women want to take an active role in participating in their treatment. CancerCare recommends that women consider the following questions to better prepare them should they face a breast cancer diagnosis:

• What kind of breast cancer do I have?

• Which treatments are available to me?

• What are the risks and benefits of those treatments?

• What is my risk that my breast cancer will come back and/or spread to another part of my body?

• Where do I go for support when I need it?

For full survey results, visit www.cancercare.org.

About the survey

The survey, sponsored by CancerCare and administered by GfK Roper Public Affairs was conducted between April 23 and May 9, 2007 via telephone among a national sample of 501 women between the ages of 50 and 65 years. Of these, 23 respondents were previously diagnosed with breast cancer. The sampling error is +/-4 percentage points. Support for the survey was provided by Novartis Oncology, (www.novartisoncology.com).

About CancerCare

CancerCare is a national nonprofit organization whose mission is to provide free, professional support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs – including counseling, education, financial assistance and practical help – are provided by trained oncology s ocial workers and are completely free of charge. Founded in 1944, CancerCare now provides individual help to more than 91,000 people each year, in addition to the 1.6 million people who gain information and resources from its websites. Find out more at www.cancercare.org or by calling 800-813-HOPE (4673).

# # #

Media Contacts
Jeanie Barnett
CancerCare
(212) 712-6137
jbarnett@cancercare.org

Dana Kahn Cooper
Cooper Communications
(732) 817-1800
(732) 239-6664 (mobile)
dana@dcoopercommunications.com


'"/>




Related medicine technology :

1. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
2. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
5. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
6. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
7. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
8. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
9. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
10. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
11. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):